Published On Jun 6, 2024
How are CRI-funded researchers bringing us closer to a world #Immune2Cancer? CRI-Mike Goguen Immuno-Informatics Postdoctoral Fellow Dr. Maxime Meylan of Dana-Farber Cancer Institute describes the focus of his work during Cancer Immunotherapy Month.
–
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.